Home › Funds › Nippon Life Global Investors Americas, Inc. › VRTX
Nippon Life Global Investors Americas, Inc. position in VRTX
VERTEX PHARMACEUTICALS INC · Health Care
Nippon Life Global Investors Americas, Inc. reported holding 34,410 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$18.0M, representing 0.72% of its reported portfolio and ranking #39 among its reported holdings. Nippon Life Global Investors Americas, Inc. has disclosed VRTX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Nippon Life Global Investors Americas, Inc.'s VRTX position evolved
Nippon Life Global Investors Americas, Inc. first disclosed a stake in VRTX in Q3 2025 at 2,830 shares (US$1.1M). The position peaked in Q2 2026 at 38,230 shares, worth US$19.0M. Across 5 filings, Nippon Life Global Investors Americas, Inc. increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 34,410 shares valued at US$18.0M — a reduction of -3,820 shares quarter over quarter.. Notable position changes include a 1429% increase in Q2 2026 (shares rose 5% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 2.83K | $1.11M | New |
| Q4 2025 | 2.25K | $1.02M | Reduce |
| Q1 2026 | 2.50K | $1.12M | Add |
| Q2 2026 | 38.23K | $18.99M | Add |
| Q3 2026 | 34.41K | $17.99M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VRTX and 13F data
VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 32 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$13.58B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VRTX
- Capital World Investors 25.97M sh · $13.58B · Q3 2026
- Capital World Investors 26.12M sh · $12.97B · Q2 2026
- Capital Research Global Investors 19.49M sh · $9.68B · Q2 2026
- Capital Research Global Investors 17.81M sh · $9.31B · Q3 2026
- Invesco Ltd 8.28M sh · $4.33B · Q3 2026
- Capital International Investors 5.06M sh · $2.65B · Q3 2026
- Franklin Resources 4.46M sh · $2.45B · Q3 2026
- LOOMIS SAYLES & CO L P 3.62M sh · $1.89B · Q3 2026
- JENNISON ASSOCIATES LLC 3.00M sh · $1.49B · Q2 2026
- ALLIANCEBERNSTEIN L.P. 3.02M sh · $1.35B · Q2 2026
- VICTORY CAPITAL MANAGEMENT INC 2.56M sh · $1.34B · Q3 2026
- Janus Henderson Group 2.13M sh · $951.79M · Q1 2026
More on Nippon Life Global Investors Americas, Inc.
FAQ
How long has Nippon Life Global Investors Americas, Inc. held VRTX?
Nippon Life Global Investors Americas, Inc. has disclosed VRTX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is Nippon Life Global Investors Americas, Inc.'s current position in VRTX?
As of Q3 2026, Nippon Life Global Investors Americas, Inc. holds 34.41K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $17.99M, representing 0.72% of its reported portfolio and ranking #39.
Has Nippon Life Global Investors Americas, Inc. been buying or selling VRTX?
In the latest 13F filing (Q3 2026), Nippon Life Global Investors Americas, Inc. reduced its position in VRTX. The position peaked in Q2 2026 at 38.23K shares.
Which other funds hold VRTX?
Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.